edronax
pfizer pfe pharmaceuticals israel ltd - reboxetine methan sulfonate - tablets - reboxetine methan sulfonate 4 mg - reboxetine - reboxetine - reboxetine is indicated for the acute treatment of depressive illness/major depression and for maintaining the clinical improvement in patients initially responding to treatment.
edronax 4mg tablets
pfizer ltd - reboxetine mesilate - oral tablet - 4mg
edronax 4mg tablets
waymade healthcare plc - reboxetine mesilate - oral tablet - 4mg
edronax 4mg tablets
dowelhurst ltd - reboxetine mesilate - oral tablet - 4mg
edronax 4mg tablets
de pharmaceuticals - reboxetine mesilate - oral tablet - 4mg
edronax 4mg tablets
sigma pharmaceuticals plc - reboxetine mesilate - oral tablet - 4mg
edronax 4mg tablets
lexon (uk) ltd - reboxetine mesilate - oral tablet - 4mg
edronax 4mg tablets
mawdsley-brooks & company ltd - reboxetine mesilate - oral tablet - 4mg
edronax 4mg tablets
necessity supplies ltd - reboxetine mesilate - oral tablet - 4mg
edronax 4mg tablets
cst pharma ltd - reboxetine mesilate - oral tablet - 4mg